O-mannosylation and N-glycosylation: Two coordinated mechanisms regulating the tumour suppressor functions of E-cadherin in cancer

Oncotarget

Volumn 7, Issue 40, 2016, Pages 65231-65246

  Carvalho, Sandra ^a,b   Oliveira, Tiago ^a   Bartels, Markus F ^c   Miyoshi, Eiji ^d   Pierce, Michael ^e   Taniguchi, Naoyuki ^f   Carneiro, Fátima ^a,g,h   Seruca, Raquel ^a,h   Reis, Celso A ^a,b,h   Strahl, Sabine ^c   Pinho, Salomé S ^a,g  

^a UNIVERSITY OF PORTO   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^e UNIVERSITY OF GEORGIA   (United States)

^f OSAKA UNIVERSITY   (Japan)

^g University of Porto   (Portugal)

^h HOSPITAL DE SÃO JOÃO   (Portugal)

Author keywords

E cadherin; Gastric cancer; N glycosylation; O mannosylation

Indexed keywords

BETA CATENIN; PROTEIN P120; UVOMORULIN; CADHERIN; MANNOSE; POLYSACCHARIDE; TUMOR SUPPRESSOR PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ADHESION; CELL MEMBRANE; CLINICAL ARTICLE; CONTROLLED STUDY; GENE OVEREXPRESSION; GENE SILENCING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOPHENOTYPING; IMMUNOPRECIPITATION; IMMUNOREACTIVITY; MGAT5 GENE; MOUSE; NONHUMAN; ONCOGENE; POMT2 GENE; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN GLYCOSYLATION; PROTEIN LOCALIZATION; PROTEIN MANNOSYLATION; PROTEIN MODIFICATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; PROTEIN SYNTHESIS; STOMACH CARCINOMA; TUMOR SUPPRESSOR GENE; WESTERN BLOTTING; ADENOCARCINOMA; ANIMAL; GLYCOSYLATION; METABOLISM; PATHOLOGY; PHYSIOLOGY; STOMACH TUMOR; TRANSGENIC MOUSE;

ADENOCARCINOMA; ANIMALS; CADHERINS; GLYCOSYLATION; HUMANS; MANNOSE; MICE; MICE, TRANSGENIC; POLYSACCHARIDES; PROTEIN PROCESSING, POST-TRANSLATIONAL; STOMACH NEOPLASMS; TUMOR SUPPRESSOR PROTEINS;

EID: 84993660248     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.11245     Document Type: Article

References (50)

1. Halbleib JM and Nelson WJ. Cadherins in development: cell adhesion, sorting, and tissue morphogenesis. Genes Dev. 2006; 20:3199-3214.
2. Macara IG, Guyer R, Richardson G, Huo Y and Ahmed M. Epithelial Homeostasis. Current biology. 2014; 24:R815-R825.
3. Leckband DE and Rooij Jd. Cadherin Adhesion and Mechanotransduction. Annual Review of Cell and Developmental Biology. 2014; 30:291-315.
4. van Roy F and Berx G. The cell-cell adhesion molecule E-cadherin. Cell Mol Life Sci. 2008; 65:3756-3788.
5. Shapiro L, Fannon AM, Kwong PD, Thompson A, Lehmann MS, Grubel G, Legrand JF, Als-Nielsen J, Colman DR and Hendrickson WA. Structural basis of cell-cell adhesion by cadherins. Nature. 1995; 374:327-337.
6. Meng W and Takeichi M. Adherens junction: molecular architecture and regulation. Cold Spring Harb Perspect Biol. 2009; 1:a002899.
7. Brasch J, Harrison OJ, Honig B and Shapiro L. Thinking outside the cell: how cadherins drive adhesion. Trends Cell Biol. 2012; 22:299-310.
8. Paredes J, Figueiredo J, Albergaria A, Oliveira P, Carvalho J, Ribeiro AS, Caldeira J, Costa AM, Simoes-Correia J, Oliveira MJ, Pinheiro H, Pinho SS, Mateus R, et al. Epithelial E-and P-cadherins: role and clinical significance in cancer. Biochim Biophys Acta. 2012; 1826:297-311.
9. Hirohashi S and Kanai Y. Cell adhesion system and human cancer morphogenesis. Cancer Sci. 2003; 94:575-581.
10. Carneiro P, Fernandes MS, Figueiredo J, Caldeira J, Carvalho J, Pinheiro H, Leite M, Melo S, Oliveira P, Simões-Correia J, Oliveira MJ, Carneiro F, Figueiredo C, et al. E-cadherin dysfunction in gastric cancer-Cellular consequences, clinical applications and open questions. FEBS Letters. 586:2981-2989.
11. Hakomori S. Glycosylation defining cancer malignancy: New wine in an old bottle. Proceedings of the National Academy of Sciences of the United States of America. 2002; 99:10231-10233.
12. Pinho SS and Reis CA. Glycosylation in cancer: mechanisms and clinical implications. Nat Rev Cancer. 2015; 15:540-555.
13. Pinho SS, Carvalho S, Marcos-Pinto R, Magalhaes A, Oliveira C, Gu J, Dinis-Ribeiro M, Carneiro F, Seruca R and Reis CA. Gastric cancer: adding glycosylation to the equation. Trends Mol Med. 2013; 19:664-676.
14. Varelas X, Bouchie MP and Kukuruzinska MA. Protein N-glycosylation in oral cancer: Dysregulated cellular networks among DPAGT1, E-cadherin adhesion and canonical Wnt signaling. Glycobiology. 2014; 24:579-591.
15. Zhu W, Leber B and Andrews DW. Cytoplasmic O-glycosylation prevents cell surface transport of E-cadherin during apoptosis. The EMBO Journal. 2001; 20:5999-6007.
16. Geng F, Zhu W, Anderson RA, Leber B and Andrews DW. Multiple post-translational modifications regulate E-cadherin transport during apoptosis. Journal of Cell Science. 2012; 125:2615-2625.
17. Steentoft C, Vakhrushev SY, Joshi HJ, Kong Y, Vester-Christensen MB, Schjoldager KTBG, Lavrsen K, Dabelsteen S, Pedersen NB, Marcos-Silva L, Gupta R, Paul Bennett E, Mandel U, et al. Precision mapping of the human O-GalNAc glycoproteome through SimpleCell technology. The EMBO Journal. 2013; 32:1478-1488.
18. Pinho SS, Figueiredo J, Cabral J, Carvalho S, Dourado J, Magalhaes A, Gartner F, Mendonfa AM, Isaji T, Gu J, Carneiro F, Seruca R, Taniguchi N, et al. E-cadherin and adherens-junctions stability in gastric carcinoma: functional implications of glycosyltransferases involving N-glycan branching biosynthesis, N-acetylglucosamin yltransferases III and V. Biochim Biophys Acta. 2013; 1830:2690-2700.
19. Pinho SS, Reis CA, Paredes J, Magalhaes AM, Ferreira AC, Figueiredo J, Xiaogang W, Carneiro F, Gartner F and Seruca R. The role of N-acetylglucosaminyltransferase III and V in the post-transcriptional modifications of E-cadherin. Hum Mol Genet. 2009; 18:2599-2608.
20. Liwosz A, Lei T and Kukuruzinska MA. N-glycosylation affects the molecular organization and stability of E-cadherin junctions. J Biol Chem. 2006; 281:23138-23149.
21. Carvalho S, Catarino TA, Dias AM, Kato M, Almeida A, Hessling B, Figueiredo J, Gartner F, Sanches JM, Ruppert T, Miyoshi E, Pierce M, Carneiro F, et al. Preventing E-cadherin aberrant N-glycosylation at Asn-554 improves its critical function in gastric cancer. Oncogene. 2015.
22. Manya H, Chiba A, Yoshida A, Wang X, Chiba Y, Jigami Y, Margolis RU and Endo T. Demonstration of mammalian protein O-mannosyltransferase activity: coexpression of POMT1 and POMT2 required for enzymatic activity. Proc Natl Acad Sci U S A. 2004; 101:500-505.
23. Loibl M and Strahl S. Protein O-mannosylation: What we have learned from baker's yeast. Biochimica et Biophysica Acta. 2013; 1833:2438-2446.
24. Neubert P and Strahl S. Protein O-mannosylation in the early secretory pathway. Current Opinion in Cell Biology. 2016; 41:100-108.
25. Praissman JL and Wells L. Mammalian O-mannosylation pathway: glycan structures, enzymes, and protein substrates. Biochemistry. 2014; 53:3066-3078.
26. Kaneko M, Alvarez-Manilla G, Kamar M, Lee I, Lee J-K, Troupe K, Zhang W-j, Osawa M and Pierce M. A novel β(1, 6)-N-acetylglucosaminyltransferase V (GnT-VB)1. FEBS Letters. 554:515-519.
27. Yoshida-Moriguchi T and Campbell KP. Matriglycan: a novel polysaccharide that links dystroglycan to the basement membrane. Glycobiology. 2015; 25:702-713.
28. Inamori K-i, Endo T, Gu J, Matsuo I, Ito Y, Fujii S, Iwasaki H, Narimatsu H, Miyoshi E, Honke K and Taniguchi N. N-Acetylglucosaminyltransferase IX Acts on the GlcNAcβ1, 2-Mana1-Ser/Thr Moiety, Forming a 2, 6-Branched Structure in Brain O-Mannosyl Glycan. Journal of Biological Chemistry. 2004; 279:2337-2340.
29. Gomez Toledo A, Raducu M, Cruces J, Nilsson J, Halim A, Larson G, Rüetschi U and Grahn A. O-Mannose and O-N-acetyl galactosamine glycosylation of mammalian a-dystroglycan is conserved in a region-specific manner. Glycobiology. 2012; 22:1413-1423.
30. Moore C and Hewitt J. Dystroglycan glycosylation and muscular dystrophy. Glycoconj J. 2009; 26:349-357.
31. Yoshida-Moriguchi T, Yu L, Stalnaker SH, Davis S, Kunz S, Oldstone MBA, Schachter H, Wells L and Campbell KP. O-Mannosyl Phosphorylation of Alpha-Dystroglycan is Required for Laminin Binding. Science (New York, NY). 2010; 327:88-92.
32. de Bernabe DB, Inamori K, Yoshida-Moriguchi T, Weydert CJ, Harper HA, Willer T, Henry MD and Campbell KP. Loss of alpha-dystroglycan laminin binding in epitheliumderived cancers is caused by silencing of LARGE. J Biol Chem. 2009; 284:11279-11284.
33. Ervasti JM and Campbell KP. Membrane organization of the dystrophin-glycoprotein complex. Cell. 1991; 66:1121-1131.
34. Riemersma M, Sandrock J, Boltje TJ, Büll C, Heise T, Ashikov A, Adema GJ, van Bokhoven H and Lefeber DJ. Disease mutations in CMP-sialic acid transporter SLC35A1 result in abnormal a-dystroglycan O-mannosylation, independent from sialic acid. Human Molecular Genetics. 2015; 24:2241-2246.
35. Vester-Christensen MB, Halim A, Joshi HJ, Steentoft C, Bennett EP, Levery SB, Vakhrushev SY and Clausen H. Mining the O-mannose glycoproteome reveals cadherins as major O-mannosylated glycoproteins. Proc Natl Acad Sci U S A. 2013; 110:21018-21023.
36. Lommel M, Winterhalter PR, Willer T, DahlhoffM, Schneider MR, Bartels MF, Renner-Muller I, Ruppert T, Wolf E and Strahl S. Protein O-mannosylation is crucial for E-cadherin-mediated cell adhesion. Proc Natl Acad Sci U S A. 2013; 110:21024-21029.
37. Harrison OJ, Jin X, Hong S, Bahna F, Ahlsen G, Brasch J, Wu Y, Vendome J, Felsovalyi K, Hampton CM, Troyanovsky RB, Ben-Shaul A, Frank J, et al. The extracellular architecture of adherens junctions revealed by crystal structures of type I cadherins. Structure (London, England: 1993). 2011; 19:244-256.
38. Yokozaki H. Molecular characteristics of eight gastric cancer cell lines established in Japan. Pathol Int. 2000; 50:767-777.
39. Oda T, Kanai Y, Oyama T, Yoshiura K, Shimoyama Y, Birchmeier W, Sugimura T and Hirohashi S. E-cadherin gene mutations in human gastric carcinoma cell lines. Proceedings of the National Academy of Sciences of the United States of America. 1994; 91:1858-1862.
40. Atsumi T, Kato K, Uno K, Iijima K, Koike T, Imatani A, Ohara S and Shimosegawa T. Pathophysiological role of the activation of p38 mitogen-activated protein kinases in poorly differentiated gastric cancer. Pathology International. 2007; 57:635-644.
41. Zhao Y, Nakagawa T, Itoh S, Inamori K, Isaji T, Kariya Y, Kondo A, Miyoshi E, Miyazaki K, Kawasaki N, Taniguchi N and Gu J. N-acetylglucosaminyltransferase III antagonizes the effect of N-acetylglucosaminyltransferase V on alpha3beta1 integrin-mediated cell migration. J Biol Chem. 2006; 281:32122-32130.
42. Taniguchi N and Kizuka Y. (2015). Chapter Two-Glycans and Cancer: Role of N-Glycans in Cancer Biomarker, Progression and Metastasis, and Therapeutics. In: Richard RD and Lauren EB, eds. Advances in Cancer Research: Academic Press, pp. 11-51.
43. Pinho S, Seruca R, Gärtner F, Yamaguchi Y, Gu J, Taniguchi N and Reis C. Modulation of E-cadherin function and dysfunction by N-glycosylation. Cell Mol Life Sci. 2011; 68:1011-1020.
44. Zhao Y-Y, Takahashi M, Gu J-G, Miyoshi E, Matsumoto A, Kitazume S and Taniguchi N. Functional roles of N-glycans in cell signaling and cell adhesion in cancer. Cancer Science. 2008; 99:1304-1310.
45. de-Freitas-Junior JCM, Carvalho S, Dias AM, Oliveira P, Cabral J, Seruca R, Oliveira C, Morgado-Díaz JA, Reis CA and Pinho SS. Insulin/IGF-I Signaling Pathways Enhances Tumor Cell Invasion through Bisecting GlcNAc N-glycans Modulation. An Interplay with E-Cadherin. PLoS ONE. 2013; 8:e81579.
46. Granovsky M, Fata J, Pawling J, Muller WJ, Khokha R and Dennis JW. Suppression of tumor growth and metastasis in Mgat5-deficient mice. Nat Med. 2000; 6:306-312.
47. Ihara S, Miyoshi E, Ko JH, Murata K, Nakahara S, Honke K, Dickson RB, Lin CY and Taniguchi N. Prometastatic effect of N-acetylglucosaminyltransferase V is due to modification and stabilization of active matriptase by adding beta 1-6 GlcNAc branching. J Biol Chem. 2002; 277:16960-16967.
48. Saito H, Nishikawa A, Gu J, Ihara Y, Soejima H, Wada Y, Sekiya C, Niikawa N and Taniguchi N. cDNA cloning and chromosomal mapping of human N-acetylglucosaminyltransferase V+. Biochem Biophys Res Commun. 1994; 198:318-327.
49. Willer T, Amselgruber W, Deutzmann R and Strahl S. Characterization of POMT2, a novel member of the PMT protein O-mannosyltransferase family specifically localized to the acrosome of mammalian spermatids. Glycobiology. 2002; 12:771-783.
50. Livak KJ and Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001; 25:402-408.